Cart
sales@molnova.com
Minesapride
CAS No. 1184662-54-1
Minesapride( —— )
Catalog No. M34335 CAS No. 1184662-54-1
Minesapride, a novel 5-hydroxytryptamine 4 (5-HT4) receptor partial agonist, is a potential gastrointestinal prokinetic agent for the treatment of irritable bowel syndrome with constipation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 283 | In Stock |
|
| 5MG | 245 | In Stock |
|
| 10MG | 363 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 786 | In Stock |
|
| 100MG | 1088 | In Stock |
|
| 200MG | 1460 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMinesapride
-
NoteResearch use only, not for human use.
-
Brief DescriptionMinesapride, a novel 5-hydroxytryptamine 4 (5-HT4) receptor partial agonist, is a potential gastrointestinal prokinetic agent for the treatment of irritable bowel syndrome with constipation.
-
DescriptionMinesapride, a novel 5-hydroxytryptamine 4 (5-HT4) receptor partial agonist, is a potential gastrointestinal prokinetic agent for the treatment of irritable bowel syndrome with constipation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
Target5-HT Receptor
-
Recptor5-HT Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1184662-54-1
-
Formula Weight454.95
-
Molecular FormulaC21H31ClN4O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NC[C@H]1CN(CC2CCN(C(CO)=O)CC2)CCO1)(=O)C3=C(OC)C=C(N)C(Cl)=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Eltoprazine
An antiaggressive agent that acts as an agonist at the 5-HT1A and 5-HT1B receptors and as an antagonist at the 5-HT2C receptor.
-
Osemozotan HCl
Osemozotan HCl (Osemozotan hydrochloride) is a novel and selective 5-HT1A receptor agonist that reduces methamphetamine-induced c-Fos expression in the medial prefrontal cortex and striatum.
-
AVN-322
A highly selective, potent, BBB penetrant and orally bioavailable 5-HT6R antagonist for the treatment of neurological disorders such as AD and schizophrenia.
